argenx SE | Investor Presentation Deck | 22 slides

argenx · 2023-03
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 1
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

1
coverage by narrative range · generated from this deck JSON
Narrative range 22 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Whole deck 22 slides 100% 22/22 slides 100% 22/22 slides · 89 hits
0/22 slides
40.9% 9/22 slides · 10 hits 50% 11/22 slides
0/22 slides
68.2% 15/22 slides

Slide inventory

22
every slide · same image gating as the playbook
01
Slide 1
front_matter
02
front_matter
03
The slide uses a thematic background with a network/molecular graphic overlay.establish_context
Open slide detailLoop · Why Now
04
The slide uses a circular graphic element to emphasize the 'revolution' in autoimmunity.present_solution
Open slide detailLoop · Why Now
05
present_solution
Open slide detailLoop · Why Now
06
The slide uses a hub-and-spoke style layout with a central mission statement and four surrounding strategic pillars.summarize
Open slide detailLoop · Why Now
07
The slide uses a waterfall-style bar chart to show quarterly revenue progression, though it is technically a standard bar chart.analyze_data
Open slide detailLoop · Why Now
08
The slide uses a combination of clinical trial charts and a logo-grid of scientific journals to establish credibility.summarize
Open slide detailLoop · Why Now
09
The slide uses a circular cluster diagram to represent four strategic pillars.summarize
Open slide detailLoop · Why Now
10
The slide uses a hub-and-spoke style diagram to categorize commercial growth drivers.present_solution
Open slide detailLoop · Quick Win Big Bet
11
The slide uses a hub-and-spoke visual metaphor to link the 'Pioneer FcRn class of medicines' to a list of specific autoantibodies.establish_context
Open slide detailLoop · Quick Win Big Bet
12
The slide uses a pyramid-like structure to display patient counts for different diseases, with 'clinical' highlighted in the top right.size_opportunity
Open slide detailLoop · Quick Win Big Bet
13
The slide uses a timeline-based layout to communicate clinical development progress and market opportunity size.plan_implementation
Open slide detailLoop · Quick Win Big Bet
14
The slide uses a visual representation of an antibody structure to explain the 'sweeping' mechanism.present_solution
Open slide detailLoop · Quick Win Big Bet
15
Includes immunofluorescence microscopy images and bar charts showing tidal volume and respiratory rate metrics.analyze_data
Open slide detailLoop · Quick Win Big Bet
16
The slide illustrates the neuromuscular junction mechanism and the clinical trial progression from healthy volunteers to patients with CMS and MuSK MG.present_solution
Open slide detailLoop · Quick Win Big Bet
17
The slide uses a horizontal layout of four circular icons with corresponding text blocks below, representing a portfolio segmentation.present_framework
Open slide detailLoop · Quick Win Big Bet
18
The slide uses a network-like background with lines connecting various logos, suggesting a collaborative ecosystem.establish_context
19
The slide uses a dual-section layout to separate commercial regulatory events from clinical trial data readouts and study initiations.plan_implementation
20
The diagram features five values: Co-Creation, Empowerment, Excellence, Humility, and Innovation.other
21
The chart uses a horizontal bar format to represent clinical trial stages (Preclinical to Commercial) for multiple indications under four main programs (VYVGARTplan_implementation
22
The slide uses a process flow diagram to illustrate the clinical trial methodology.present_framework